Last 12 months
Inside the activity.
0 purchase rows · 143 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 34 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 92 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2014 Filed Feb 25, 2014 23:12 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 3,050 | $123.18 | $375,699.00 |
DisclosureSEC source: 0001127602-14-008415 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,255 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 23:15 UTC |
Thomson Andrew JSenior Vice President
|
Tax withholdingCommon Stock | 780 | $123.18 | $96,080.40 |
DisclosureSEC source: 0001127602-14-008419 · form4.xml · nonDerivative · entry 1 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,379 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 23:24 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 12,360 | $124.30 | $1,536,348.00 |
DisclosureSEC source: 0001127602-14-008440 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,593 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.93 to $124.82, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 23:24 UTC |
Malus Alan JExecutive Vice President
|
Tax withholdingCommon Stock | 2,407 | $123.18 | $296,494.26 |
DisclosureSEC source: 0001127602-14-008440 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,953 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 23:26 UTC |
Loewald Thomas WSenior Vice President
|
Tax withholdingCommon Stock | 1,242 | $123.18 | $152,989.56 |
DisclosureSEC source: 0001127602-14-008443 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,241 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 23:27 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 190 | $123.18 | $23,404.20 |
DisclosureSEC source: 0001127602-14-008447 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,052 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 23:28 UTC |
Pesicka Edward ASenior Vice President
|
Tax withholdingCommon Stock | 2,133 | $123.18 | $262,742.94 |
DisclosureSEC source: 0001127602-14-008450 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,001 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 23:29 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Tax withholdingCommon Stock | 968 | $123.18 | $119,238.24 |
DisclosureSEC source: 0001127602-14-008452 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,563 Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:12 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,825 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-006861 · form4.xml · derivative · entry 7 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,825 Underlying: Common Stock · 1,825 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first and second installments became exercisable on March 5, 2012 and 2013, and the next two installments become exercisable on March 5, 2014 and 2015. Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:12 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,450 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-14-006861 · form4.xml · derivative · entry 6 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,450 Underlying: Common Stock · 8,450 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first and second installments became exercisable on February 23, 2012, and 2013, and the next two installments become exercisable on February 23, 2014 and 2015. Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:12 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,450 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-006861 · form4.xml · derivative · entry 5 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Underlying: Common Stock · 6,450 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2011, 2012 and 2013, and the next installment becomes exercisable on March 5, 2014. Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:12 UTC |
Thomson Andrew JSenior Vice President
|
SaleCommon Stock | 16,725 | $123.14 | $2,059,516.50 |
DisclosureSEC source: 0001127602-14-006861 · form4.xml · nonDerivative · entry 4 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,159 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.96 to $123.27, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:12 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionCommon Stock | 1,825 | $49.49 | $90,319.25 |
DisclosureSEC source: 0001127602-14-006861 · form4.xml · nonDerivative · entry 3 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:12 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionCommon Stock | 8,450 | $54.97 | $464,496.50 |
DisclosureSEC source: 0001127602-14-006861 · form4.xml · nonDerivative · entry 2 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:12 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionCommon Stock | 6,450 | $49.49 | $319,210.50 |
DisclosureSEC source: 0001127602-14-006861 · form4.xml · nonDerivative · entry 1 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2014 Filed Feb 18, 2014 23:14 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 23,582 | $123.74 | $2,918,036.68 |
DisclosureSEC source: 0001127602-14-006863 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,147.53 Read SEC document |
| February 13, 2014 Filed Feb 18, 2014 23:13 UTC |
MANZI JIM PDirector
|
SaleCommon Stock | 4,400 | $122.36 | $538,384.00 |
DisclosureSEC source: 0001127602-14-006862 · form4.xml · nonDerivative · entry 1 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,997 Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 00:04 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,734 | $0.00 Strike: $36.10 | $0.00 |
DisclosureSEC source: 0001127602-14-005674 · form4.xml · derivative · entry 6 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,734 shares Expires 2016-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal installments on February 26, 2010, 2011 and 2012. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 00:04 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,800 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-005674 · form4.xml · derivative · entry 5 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 4,800 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2011, 2012, and 2013, and the next installment becomes exercisable on March 5, 2014. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 00:04 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
SaleCommon Stock | 9,234 | $117.72 | $1,087,026.48 |
DisclosureSEC source: 0001127602-14-005674 · form4.xml · nonDerivative · entry 3 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,242 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.50 to $118.23, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 00:04 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 2,734 | $36.10 | $98,697.40 |
DisclosureSEC source: 0001127602-14-005674 · form4.xml · nonDerivative · entry 2 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 00:04 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 4,800 | $49.49 | $237,552.00 |
DisclosureSEC source: 0001127602-14-005674 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2014 Filed Feb 7, 2014 23:59 UTC |
WILVER PETER MSr. VP & CFO
|
SaleCommon Stock | 21,997 | $117.61 | $2,587,067.17 |
DisclosureSEC source: 0001127602-14-005177 · form4.xml · nonDerivative · entry 3 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,305 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.57 to $117.72, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 87,500 | $0.00 Strike: $57.58 | $0.00 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · derivative · entry 9 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,500 shares Expires 2015-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested in five equal annual installments on May 15, 2009, 2010, 2011, 2012, and 2013. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 63,369 | $117.61 | $7,452,828.09 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · nonDerivative · entry 6 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,729.53 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.00 to $117.89, inclusive. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 32,500 | $116.47 | $3,785,275.00 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · nonDerivative · entry 5 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,098.53 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.99, inclusive. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 2,896 | $115.60 | $334,777.60 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · nonDerivative · entry 4 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,598.53 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.04 to $115.99, inclusive. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 87,500 | $57.58 | $5,038,250.00 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · nonDerivative · entry 3 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,494.53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:25 UTC |
Parrett William GDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $58.40 | $0.00 |
DisclosureSEC source: 0001127602-14-005173 · form4.xml · derivative · entry 3 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2015-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments on July 10, 2009, 2010, and 2011. Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:25 UTC |
Parrett William GDirector
|
SaleCommon Stock | 18,000 | $114.33 | $2,057,940.00 |
DisclosureSEC source: 0001127602-14-005173 · form4.xml · nonDerivative · entry 2 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,188 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.33 to $114.34, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:25 UTC |
Parrett William GDirector
|
Exercise / conversionCommon Stock | 15,000 | $58.40 | $876,000.00 |
DisclosureSEC source: 0001127602-14-005173 · form4.xml · nonDerivative · entry 1 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:31 UTC |
MANZI JIM PDirector
|
GiftCommon Stock | 1,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-005175 · form4.xml · nonDerivative · entry 2 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,397 Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:31 UTC |
MANZI JIM PDirector
|
SaleCommon Stock | 6,000 | $114.26 | $685,560.00 |
DisclosureSEC source: 0001127602-14-005175 · form4.xml · nonDerivative · entry 1 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,152 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.20 to $114.39, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:59 UTC |
WILVER PETER MSr. VP & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 69,900 | $0.00 Strike: $36.10 | $0.00 |
DisclosureSEC source: 0001127602-14-005177 · form4.xml · derivative · entry 4 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 69,900 shares Expires 2016-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal installments on February 26, 2010, 2011, and 2012. Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:59 UTC |
WILVER PETER MSr. VP & CFO
|
SaleCommon Stock | 69,900 | $114.45 | $8,000,055.00 |
DisclosureSEC source: 0001127602-14-005177 · form4.xml · nonDerivative · entry 2 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,302 Read SEC document |
| February 06, 2014 Filed Feb 7, 2014 23:59 UTC |
WILVER PETER MSr. VP & CFO
|
Exercise / conversionCommon Stock | 69,900 | $36.10 | $2,523,390.00 |
DisclosureSEC source: 0001127602-14-005177 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2014 Filed Feb 8, 2014 00:06 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,250 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-005179 · form4.xml · derivative · entry 6 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 Underlying: Common Stock · 7,250 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first and second installments became excercisable on March 5, 2012, and 2013, and the next two installments become exercisable on March 5, 2014 and 2015. Read SEC document |
| February 06, 2014 Filed Feb 8, 2014 00:06 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,187 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-005179 · form4.xml · derivative · entry 5 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,063 Underlying: Common Stock · 15,187 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2011, 2012, and 2013, and the next installment becomes exercisable on March 5, 2014. Read SEC document |
| February 06, 2014 Filed Feb 8, 2014 00:06 UTC |
Loewald Thomas WSenior Vice President
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-005179 · form4.xml · nonDerivative · entry 4 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,483 Read SEC document |
| February 06, 2014 Filed Feb 8, 2014 00:06 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 22,437 | $114.24 | $2,563,202.88 |
DisclosureSEC source: 0001127602-14-005179 · form4.xml · nonDerivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,983 Read SEC document |
| February 06, 2014 Filed Feb 8, 2014 00:06 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 7,250 | $49.49 | $358,802.50 |
DisclosureSEC source: 0001127602-14-005179 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2014 Filed Feb 8, 2014 00:06 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 15,187 | $49.49 | $751,604.63 |
DisclosureSEC source: 0001127602-14-005179 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $57.58 | $0.00 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · derivative · entry 8 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 100,000 shares Expires 2015-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested in five equal annual installments on May 15, 2009, 2010, 2011, 2012, and 2013. Read SEC document |
| February 06, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 110,000 | $114.38 | $12,581,800.00 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,994.53 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.12 to $114.78, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. Read SEC document |
| February 06, 2014 Filed Feb 11, 2014 00:29 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 100,000 | $57.58 | $5,758,000.00 |
DisclosureSEC source: 0001127602-14-005451 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,994.53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Since the date of the reporting person's last ownership report, he transferred 121,918 shares of TMO common stock and employee stock options to purchase 524,370 shares of TMO common stock (10,487 stock options granted on 2/26/13; 76,903 stock options granted on 2/23/11; 249,480 stock options granted on 11/21/2009; and 187,500 stock options granted on 5/15/2008) to his ex-wife pursuant to a divorce decree. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife. Read SEC document |
| December 31, 2013 Filed Jan 3, 2014 21:32 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 258.19 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-14-000569 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,371.71 Underlying: Common Stock · 258.19 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2013, at a price of $111.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2013, at a price of $111.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2013, at a price of $111.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| September 28, 2013 Filed Oct 1, 2013 20:30 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 309.11 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-13-037447 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,113.52 Underlying: Common Stock · 309.11 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of September 28, 2013, at a price of $93.01 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 28, 2013, at a price of $93.01 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 28, 2013, at a price of $93.01 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| September 16, 2013 Filed Sep 17, 2013 20:33 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 4,000 | $91.87 | $367,480.00 |
DisclosureSEC source: 0001127602-13-027347 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,360 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2012. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.41 to $92.22, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 26, 2013 Filed Aug 27, 2013 20:57 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 1,091 | $90.36 | $98,582.76 |
DisclosureSEC source: 0001127602-13-026104 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,302 Read SEC document |
| August 26, 2013 Filed Aug 27, 2013 20:58 UTC |
Thomson Andrew JSenior Vice President
|
Tax withholdingCommon Stock | 981 | $90.36 | $88,643.16 |
DisclosureSEC source: 0001127602-13-026105 · form4.xml · nonDerivative · entry 1 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,159 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.